Pharma Deals Review, Vol 2008, No 94 (2008)

Font Size:  Small  Medium  Large

Endo In-licenses Novartis Pain Product

Business Review Editor

Abstract


Endo Pharmaceuticals obtained the exclusive US marketing rights for the prescription NSAID Voltaren® Gel from Novartis for US$110 M.

Full Text: pdf

Add comment

Creative Commons License
This work is licensed under a Creative Commons Attribution 3.0 License.